An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions in a Chinese Population.

Clinical trial NCT07124039 · COMPLETED

Trial details

NCT number: NCT07124039
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Kidney Disease Type 2 Diabetes Mellitus

Start date: 2025-07-16
Primary completion: 2026-02-28
Enrollment: 6537

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.